Anavex Life Sciences
AVXL
AVXL
65 hedge funds and large institutions have $32.6M invested in Anavex Life Sciences in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.87% less ownership
Funds ownership: 23.8% → 22.93% (-0.87%)
21% less capital invested
Capital invested by funds: $41.5M → $32.6M (-$8.91M)
55% less call options, than puts
Call options by funds: $394K | Put options by funds: $869K
Holders
65
Holding in Top 10
1
Calls
$394K
Puts
$869K
Top Buyers
| 1 | +$250K | |
| 2 | +$216K | |
| 3 | +$160K | |
| 4 |
Morgan Stanley
New York
|
+$133K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$89.7K |
Top Sellers
| 1 | -$517K | |
| 2 | -$102K | |
| 3 | -$79K | |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$77K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$63K |